Valuation: Ibnsina Pharma

Market Cap 13.89B 279M 241M 225M 207M 389M 26.55B 395M 2.64B 1.04B 13.31B 1.05B 1.02B 43.99B P/E 2026 *
11.3x
P/E 2027 * 7.74x
Enterprise Value 19.71B 396M 342M 320M 293M 552M 37.67B 560M 3.75B 1.47B 18.88B 1.49B 1.45B 62.41B EV / Sales 2026 *
0.22x
EV / Sales 2027 * 0.19x
Free-Float
70.08%
Yield 2026 *
2.18%
Yield 2027 * 4.21%
1 day+1.32%
1 week+17.18%
Current month+21.20%
1 month+18.90%
3 months+21.95%
6 months+9.37%
Current year+17.58%
1 week 13.05
Extreme 13.05
16.93
1 month 11.2
Extreme 11.2
16.93
Current year 9.63
Extreme 9.63
16.93
1 year 9.63
Extreme 9.63
16.93
3 years 1.78
Extreme 1.78
16.93
5 years 1.1
Extreme 1.101
16.93
10 years 1.1
Extreme 1.101
16.93
Manager TitleAgeSince
Chief Executive Officer - 2000-12-17
Chief Executive Officer - 2000-12-17
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - 2000-12-17
Director/Board Member - 2000-12-17
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.32%+17.18%+35.76%+535.02% 279M
+2.93%+0.70%-23.66%-23.95% 15.83B
+2.23%+1.24%-26.06%-34.88% 7.38B
+2.69%+2.44%-22.65%-11.95% 6.21B
-1.42%-2.55%-7.44%-33.18% 3.98B
+0.68%+0.10%-22.19%-37.60% 3.3B
-1.19%-2.06%-41.84%-24.45% 3.12B
-2.23%-7.11%-0.45%-39.83% 2.95B
+11.05%+10.88%+119.48% - 2.78B
0.00%-3.88%-14.65%+5.61% 2.62B
Average +1.61%-0.60%-0.37%+37.20% 4.85B
Weighted average by Cap. +2.00%-0.79%-13.19%-21.82%

Financials

2026 *2027 *
Net sales 89.87B 1.8B 1.56B 1.46B 1.34B 2.52B 172B 2.56B 17.11B 6.71B 86.1B 6.78B 6.63B 285B 101B 2.03B 1.76B 1.64B 1.51B 2.83B 193B 2.88B 19.26B 7.56B 96.94B 7.63B 7.46B 320B
Net income 1.33B 26.64M 23.05M 21.52M 19.74M 37.13M 2.54B 37.72M 253M 99.11M 1.27B 100M 97.86M 4.2B 1.92B 38.65M 33.43M 31.22M 28.64M 53.87M 3.68B 54.73M 366M 144M 1.84B 145M 142M 6.1B
Net Debt 5.82B 117M 101M 94.36M 86.57M 163M 11.12B 165M 1.11B 435M 5.57B 439M 429M 18.42B 5.77B 116M 100M 93.63M 85.9M 162M 11.03B 164M 1.1B 431M 5.53B 435M 426M 18.28B
Logo Ibnsina Pharma
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Employees
5,500
Date Price Change Volume
26-08-09 EGP 13.78 +1.32% 10,388,402
26-08-06 EGP 13.60 +3.82% 18,844,750
26-08-05 EGP 13.10 -2.02% 16,122,451
26-08-04 EGP 13.37 -5.24% 46,747,584
26-08-03 EGP 14.11 +19.98% 79,327,908
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.78EGP
Average target price
17.26EGP
Spread / Average Target
+25.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ISPH Stock